Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000341607

Medchemexpress LLC 4-thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1h)-isoquino | 1235032-75-3 | 98.9% | 25 MG
SDP

Catalog No. 5000341607
Encompass_Preferred

Bcl-xL antagonist 2 is a potent, selective, and orally active antagonist of BCL-XL with an IC50 of 0.091 μM and a Ki of 65 nM. It promotes the apoptosis of cancer cells.

  • Potent and selective antagonist of BCL-XL.
  • Orally active.
  • Promotes the apoptosis of cancer cells.
  • Potential for research of chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL).

Catalog No. 50-003-41607 Supplier Medchemexpress LLC Supplier No. 25MGHY12908
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Bcl-xL antagonist 2 is a potent, selective, and orally active antagonist of BCL-XL with an IC50 of 0.091 μM and a Ki of 65 nM. It promotes the apoptosis of cancer cells.

  • Potent and selective antagonist of BCL-XL.
  • Orally active.
  • Promotes the apoptosis of cancer cells.
  • Potential for research of chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.